Patents by Inventor Ulrich Ixkes

Ulrich Ixkes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6420410
    Abstract: A method for inhibiting neoplastic cells and related conditions by exposing them to N,N′-substituted benzimidazol-2-ones.
    Type: Grant
    Filed: August 16, 2000
    Date of Patent: July 16, 2002
    Assignee: Cell Pathways, Inc.
    Inventors: Gerhard Sperl, Ulrich Ixkes, Rifat Pamukcu, Gary A. Piazza
  • Publication number: 20020082280
    Abstract: A method for inhibiting neoplasia, particularly cancerous and precancerous lesions by exposing the affected cells to benzimidazole derivatives.
    Type: Application
    Filed: November 5, 2001
    Publication date: June 27, 2002
    Inventors: Gerhard Sperl, Rifat Pamukcu, Ulrich Ixkes, Gary A. Piazza
  • Patent number: 6348032
    Abstract: A method for inhibiting neoplasia, particularly cancerous and precancerous lesions by exposing the affected cells to benzimidazole derivatives.
    Type: Grant
    Filed: November 23, 1998
    Date of Patent: February 19, 2002
    Assignee: Cell Pathways, Inc.
    Inventors: Gerhard Sperl, Rifat Pamukcu, Ulrich Ixkes, Gary A. Piazza
  • Patent number: 6211177
    Abstract: A method for inhibiting neoplasia, particularly cancerous and precancerous lesions, by exposing the affected cells to substituted 2-aryl-benzimidazoles.
    Type: Grant
    Filed: November 24, 1998
    Date of Patent: April 3, 2001
    Assignee: Cell Pathways, Inc.
    Inventors: Gerhard Sperl, Ulrich Ixkes, Rifat Pamukcu, Gary A. Piazza